Simplified Canadian Definition for Familial Hypercholesterolemia

Area of Science:

• Cardiovascular Medicine
• Genetics
• Metabolic Disorders

Background:

• Familial Hypercholesterolemia (FH) is an autosomal codominant disorder.
• Elevated LDL-C in FH significantly increases the risk of premature atherosclerotic cardiovascular disease.
• Current FH diagnostic criteria are complex and often difficult to apply.

Purpose of the Study:

• To propose and validate a novel, simplified definition for diagnosing Familial Hypercholesterolemia.
• To improve the ease and accuracy of FH identification in clinical practice.

Main Methods:

• Developed a simplified FH definition incorporating LDL-C levels, clinical features (tendon xanthomas), and genetic mutations (LDLR, APOB, PCSK9).
• Utilized a large database (>3.3 million subjects) to establish LDL-C cut-points.
• Conducted concordance analyses comparing the new definition with established criteria (Simon Broome Register, Dutch Lipid Clinic Network) in 5987 Canadian individuals.

Main Results:

• The proposed FH definition demonstrated high diagnostic performance.
• Excellent agreement was observed between the new definition and existing algorithms (κ = 0.969 for Simon Broome, κ = 0.966 for Dutch Lipid Clinic Network).
• The definition is adapted for the Canadian population.

Conclusions:

• The novel simplified FH definition is comparable in diagnostic performance to current criteria.
• This simplified approach is expected to facilitate the diagnosis of FH patients.
• Improved FH diagnosis can lead to better management of atherosclerotic cardiovascular disease risk.